[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Asia Pacific Urinalysis Test Market Size Study, by Product (Instruments, Consumables), by Application (Disease screening, Pregnancy and fertility), by End User (Hospitals and clinics, Diagnostic laboratories, Home care) and Country Forecasts 2022-2032

July 2024 | 200 pages | ID: A1AB6FFF4572EN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Asia Pacific Urinalysis Test Market is valued at approximately USD 1428.84 million in 2023 and is anticipated to grow with a healthy growth rate of more than 2.27% over the forecast period 2024-2032. A urinalysis is a diagnostic tool providing insights into urinary system health. It examines urine's physical, chemical, and microscopic characteristics. Colour and transparency indicate hydration and potential substances such as proteins or bacteria. Specific gravity measures urine concentration, reflecting hydration levels, while pH levels show diet and health condition impacts. Proteinuria signals kidney issues, glucose suggests diabetes, and ketones indicate fat use for energy. Elevated bilirubin and urobilinogen point to liver or bile duct problems. Nitrites and leukocyte esterase indicate infections or inflammation. Microscopic analysis helps diagnose kidney disease by identifying cells, bacteria, and crystals. The Asia Pacific Urinalysis Test market is growing due to rising urinary tract infections and kidney diseases, increasing demand for urinalysis tests. Point-of-care testing solutions boost market expansion by offering convenience and rapid results, particularly in remote areas. Awareness of preventive healthcare drives more individuals to choose regular urine tests. Technological advancements, such as smartphone apps for result analysis, further enhance market opportunities. These trends are propelling the Asia Pacific Urinalysis Test Market towards significant growth.

The Asia Pacific Urinalysis Test Market is significantly influenced by the rising prevalence of chronic diseases in the region, driven by an ageing population, changing lifestyles, and increasing obesity rates. Chronic conditions such as diabetes, kidney diseases, and urinary tract infections require regular monitoring through urinalysis tests, boosting the demand for such diagnostics. However, the market faces restraints such as limited access to quality healthcare in rural areas, high costs of advanced testing devices, and inadequate healthcare infrastructure in certain regions. Economic constraints further limit investments in healthcare technologies, while varying regulatory frameworks across countries pose challenges for market entry and expansion. Additionally, limited awareness and education about the importance of regular urinalysis testing impact market growth. Addressing these challenges is essential for the sustainable expansion of the urinalysis test market in the Asia Pacific region.

The key Countries considered for the Asia Pacific Urinalysis Test market study include China, India, Japan, South Korea, Australia and the Rest of Asia Pacific. China is the dominating region in terms of revenue in the Asia Pacific Urinalysis Test Market. China has a massive population, including a significant ageing demographic. The country's ageing population is more prone to chronic diseases that require regular monitoring, including urinalysis tests. This large and growing patient population drives the demand for urinalysis tests in China. China has been rapidly expanding its healthcare infrastructure, especially in urban areas, improving access to healthcare services and diagnostic facilities. This expansion has increased the availability and affordability of urinalysis tests across the country, further fueling market growth. The Chinese government has been actively promoting preventive healthcare measures and increasing healthcare spending, which has contributed to the growth of the urinalysis test market. On the other hand, the market in India is expected to develop at the fastest rate over the forecast period.

Major market player included in this report are:
Sysmex Corporation
Arkray, Inc.
Nipro Corporation
Abbott Laboratories Japan Ltd.
Roche Diagnostics (Shanghai) Co., Ltd.
Siemens Healthcare Pty Ltd.
Mindray Medical International Limited
URIT Medical Electronic Group Co., Ltd.
BioSino Bio-Technology & Science Inc.
EKF Diagnostics Australia Pty Ltd.

The detailed segments and sub-segments of the market are explained below:

By Product
Instruments
Consumables

By Application
Disease screening
Pregnancy and fertility

By End User
Hospitals and clinics
Diagnostic laboratories
Home care
By Region:
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
CHAPTER 1. ASIA PACIFIC URINALYSIS TEST MARKET DEFINITION AND RESEARCH ASSUMPTIONS

1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
  1.3.1. Inclusion & Exclusion
  1.3.2. Limitations
  1.3.3. Supply Side Analysis
    1.3.3.1. Availability
    1.3.3.2. Infrastructure
    1.3.3.3. Regulatory Environment
    1.3.3.4. Market Competition
    1.3.3.5. Economic Viability (Consumer’s Perspective)
  1.3.4. Demand Side Analysis
    1.3.4.1. Regulatory frameworks
    1.3.4.2. Technological Advancements
    1.3.4.3. Environmental Considerations
    1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Asia Pacific Urinalysis Test Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
  2.3.1. By Product
  2.3.2. By Application
  2.3.3. By End User
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion

CHAPTER 3. ASIA PACIFIC URINALYSIS TEST MARKET DYNAMICS

3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities

CHAPTER 4. ASIA PACIFIC URINALYSIS TEST MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model
  4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
  4.2.5. Environmental
  4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

CHAPTER 5. ASIA PACIFIC URINALYSIS TEST MARKET SIZE & FORECASTS BY PRODUCT 2022-2032

5.1. Instruments
5.2. Consumables

CHAPTER 6. ASIA PACIFIC URINALYSIS TEST MARKET SIZE & FORECASTS BY APPLICATION 2022-2032

6.1. Disease screening
6.2. Pregnancy and fertility

CHAPTER 7. ASIA PACIFIC URINALYSIS TEST MARKET SIZE & FORECASTS BY END USER 2022-2032

7.1. Hospitals and clinics
7.2. Diagnostic laboratories
7.3. Home care

CHAPTER 8. ASIA PACIFIC URINALYSIS TEST MARKET SIZE & FORECASTS BY COUNTRY 2022-2032

8.1. China Urinalysis Test Market
  8.1.1. Product breakdown size & forecasts, 2022-2032
  8.1.2. Application breakdown size & forecasts, 2022-2032
  8.1.3. End User breakdown size & forecasts, 2022-2032
8.2. India Urinalysis Test Market
8.3. Japan Urinalysis Test Market
8.4. Australia Urinalysis Test Market
8.5. South Korea Urinalysis Test Market
8.6. Rest of Asia Pacific Urinalysis Test Market

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Key Company SWOT Analysis
  9.1.1. Company
  9.1.2. Company
  9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
  9.3.1. Sysmex Corporation
    9.3.1.1. Key Information
    9.3.1.2. Overview
    9.3.1.3. Financial (Subject to Data Availability)
    9.3.1.4. Product Summary
    9.3.1.5. Market Strategies
  9.3.2. Arkray, Inc.
  9.3.3. Nipro Corporation
  9.3.4. Abbott Laboratories Japan Ltd.
  9.3.5. Roche Diagnostics (Shanghai) Co., Ltd.
  9.3.6. Siemens Healthcare Pty Ltd.
  9.3.7. Mindray Medical International Limited
  9.3.8. URIT Medical Electronic Group Co., Ltd.
  9.3.9. BioSino Bio-Technology & Science Inc.
  9.3.10. EKF Diagnostics Australia Pty Ltd.

CHAPTER 10. RESEARCH PROCESS

10.1. Research Process
  10.1.1. Data Mining
  10.1.2. Analysis
  10.1.3. Market Estimation
  10.1.4. Validation
  10.1.5. Publishing
10.2. Research Attributes

LIST OF TABLES

TABLE 1. Asia Pacific Urinalysis Test market, report scope
TABLE 2. Asia Pacific Urinalysis Test market estimates & forecasts by Country 2022-2032 (USD Million)
TABLE 3. Asia Pacific Urinalysis Test market estimates & forecasts by Product 2022-2032 (USD Million)
TABLE 4. Asia Pacific Urinalysis Test market estimates & forecasts by Application 2022-2032 (USD Million)
TABLE 5. Asia Pacific Urinalysis Test market estimates & forecasts by End User 2022-2032 (USD Million)
TABLE 6. Asia Pacific Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. Asia Pacific Urinalysis Test market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. Asia Pacific Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. Asia Pacific Urinalysis Test market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. Asia Pacific Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. Asia Pacific Urinalysis Test market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 12. Asia Pacific Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 13. Asia Pacific Urinalysis Test market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 14. Asia Pacific Urinalysis Test market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 15. Asia Pacific Urinalysis Test market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 16. China Urinalysis Test market estimates & forecasts, 2022-2032 (USD Million)
TABLE 17. China Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 18. China Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 19. India Urinalysis Test market estimates & forecasts, 2022-2032 (USD Million)
TABLE 20. India Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 21. India Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 22. Japan Urinalysis Test market estimates & forecasts, 2022-2032 (USD Million)
TABLE 23. Japan Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 24. Japan Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 25. Australia Urinalysis Test market estimates & forecasts, 2022-2032 (USD Million)
TABLE 26. Australia Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 27. Australia Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 28. South Korea Urinalysis Test market estimates & forecasts, 2022-2032 (USD Million)
TABLE 29. South Korea Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 30. South Korea Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 32. RoAPAC Urinalysis Test market estimates & forecasts, 2022-2032 (USD Million)
TABLE 33. RoAPAC Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 34. RoAPAC Urinalysis Test market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 35. List of secondary sources, used in the study of Asia Pacific Urinalysis Test Market.
TABLE 36. List of primary sources, used in the study of Asia Pacific Urinalysis Test Market.
TABLE 37. Years considered for the study.
TABLE 38. Exchange rates considered.

LIST OF FIGURES

FIG 1. Asia Pacific Urinalysis Test market, research methodology
FIG 2. Asia Pacific Urinalysis Test market, market estimation techniques
FIG 3. Asia Pacific market size estimates & forecast methods.
FIG 4. Asia Pacific Urinalysis Test market, key trends 2023
FIG 5. Asia Pacific Urinalysis Test market, growth prospects 2022-2032
FIG 6. Asia Pacific Urinalysis Test market, porters 5 force model
FIG 7. Asia Pacific Urinalysis Test market, pestel analysis
FIG 8. Asia Pacific Urinalysis Test market, value chain analysis
FIG 9. Asia Pacific Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 10. Asia Pacific Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 11. Asia Pacific Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 12. Asia Pacific Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 13. Asia Pacific Urinalysis Test market by segment, 2022 & 2032 (USD Million)
FIG 14. Asia Pacific Urinalysis Test market, Country snapshot 2022 & 2032
FIG 15. Asia pacific Urinalysis Test market 2022 & 2032 (USD Million)
FIG 16. Asia Pacific Urinalysis Test market, company market share analysis (2023)


More Publications